Ro24-7429
≥98%
- Product Code: 107385
CAS:
139339-45-0
Molecular Weight: | 272.73 g./mol | Molecular Formula: | C₁₄H₁₃ClN₄ |
---|---|---|---|
EC Number: | MDL Number: | ||
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | 2-8°C, sealed, dry |
Product Description:
It is primarily investigated for its potential in antiviral therapies, particularly in targeting HIV. The compound has shown promise in inhibiting viral replication by interfering with the function of the viral Tat protein, which is crucial for the transcription of the HIV genome. This mechanism makes it a candidate for developing treatments aimed at reducing viral load in infected individuals. Additionally, its application extends to research settings, where it is used to study the molecular biology of HIV and to explore new therapeutic strategies for managing the infection.
Sizes / Availability / Pricing:
Size (g) | Availability | Price | Quantity |
---|---|---|---|
0.005 | 10-20 days | ฿22,500.00 |
+
-
|
0.025 | 10-20 days | ฿67,500.00 |
+
-
|
0.100 | 10-20 days | ฿162,000.00 |
+
-
|
Ro24-7429
It is primarily investigated for its potential in antiviral therapies, particularly in targeting HIV. The compound has shown promise in inhibiting viral replication by interfering with the function of the viral Tat protein, which is crucial for the transcription of the HIV genome. This mechanism makes it a candidate for developing treatments aimed at reducing viral load in infected individuals. Additionally, its application extends to research settings, where it is used to study the molecular biology of HIV and to explore new therapeutic strategies for managing the infection.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :